Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

~33 mi. (Miyazaki, Japan, +45 more cities)

University of Miyazaki Hospital

Essential Thrombocythemia

ropeginterferon alfa-2B

Other

SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients

~63 mi. (Sakaiishi, Japan, +163 more cities)

Investigational Site Number :3920014

CEACAM5 Expression

Non-Squamous Non-Small Cell Lung Carcinoma

tusamitamab ravtansine

chemotherapy, +1 more type

A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer

~63 mi. (Sakaiishi, Japan, +112 more cities)

Local Institution

Non-Small Cell Lung Carcinoma

carboplatin, +5 more drugs

chemotherapy, +1 more type

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

~63 mi. (Sakaiishi, Japan, +228 more cities)

Kinki-Chuo Chest Medical Center /ID# 216461

MET Expression

Non-Small Cell Lung Carcinoma

telisotuzumab vedotin

chemotherapy, +1 more type

Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

~64 mi. (Kawagoshi, Japan, +201 more cities)

Saitama Medical Center /ID# 222016

Myelodysplastic Syndromes

azacitidine, +1 more drug

chemotherapy

Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)

~80 mi. (Nakaku, Japan, +62 more cities)

National Hospital Organization Nagoya Medical Center

MS4A1 Expression

Follicular Lymphoma, +1 more condition

bendamustine, +3 more drugs

chemotherapy, +2 more types

A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

~81 mi. (Kotō, Japan, +172 more cities)

Japanese Foundation for Cancer Research

RET Fusion

Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

A Study of LOXO-292 in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer

~81 mi. (Kotō, Japan, +78 more cities)

Japanese Foundation for Cancer Research

RET Fusion, +1 more biomarker

Adrenal Gland Pheochromocytoma, +5 more conditions

selpercatinib

targeted therapy

A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

~81 mi. (Kotō, Japan, +184 more cities)

Japanese Foundation for Cancer Research

RET Fusion

Non-Squamous Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

~81 mi. (Kotō, Japan, +143 more cities)

Japanese Foundation for Cancer Research

RET Mutation

Thyroid Gland Medullary Carcinoma

selpercatinib

targeted therapy

Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

~81 mi. (Kotō, Japan, +79 more cities)

Japanese Foundation for Cancer Research

Mantle Cell Lymphoma

pirtobrutinib

targeted therapy

Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection

~81 mi. (Kotō, Japan, +34 more cities)

Cancer Institute Hospital Of JFCR

Colorectal Adenocarcinoma

trifluridine/tipiracil hydrochloride

chemotherapy